EVUSHELD long - acting antibody combination retains neutralizing activity against Omicron variant in studies from Oxford and Washington Universities

AstraZeneca’s antibody combination for the prevention of Covid-19 retains neutralization activity against the SARS-CoV-2 variant, according to new data from two UK and US studies. A new study suggests that a new batch of antibodies could be used to prevent the disease.

Source: businesswire.com
Published on 2021-12-23